116
Participants
Start Date
October 23, 2020
Primary Completion Date
August 17, 2021
Study Completion Date
August 17, 2021
Canakinumab
Body weight adjusted dose in 250 ml 5% dextrose solution i.v. over 2 hours
Placebo
Aqua ad injectabilia in 250 ml 5% dextrose solution i.v. over 2 hours
University Hospital Lausanne, Lausanne
University Hospital Geneva, Geneva
Hopital du Jura, Delémont
University Hospital Bern, Bern
University Hospital Basel, Basel
University Medical Clinic Aarau, Aarau
Cantonal Hospital Lucerne, Lucerne
University Hospital Zürich, Zurich
Cantonal Hospital St Gallen, Sankt Gallen
Collaborators (1)
Novartis
INDUSTRY
Swiss National Science Foundation
OTHER
University Hospital, Basel, Switzerland
OTHER